TO STUDY THE THE EFFECT OF MUSTAKATUKA CHURNA IN RASIED LIPID LEVELS
- Conditions
- Health Condition 1: E788- Other disorders of lipoprotein metabolism
- Registration Number
- CTRI/2022/02/040171
- Lead Sponsor
- Dr Akanksha Dandekar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
newly diagnosed dyslipidemia patients
Lipid Panel:
SR. NO. LIPID PANEL BORDERLINE
1 Total Cholesterol 200 to 293 mg/dl
2 LDL-C 130 to 159 mg /dl
3 HDL-C 35 to 45 mg/dl
4 Triglycerides 150-199 mg/dl
Age: <30, >75yrs
Pregnant women & lactating mothers.
Patients having history of serious cardiac disorders like myocardial
infarction, cardiac failure, COPD.
Untreated thyroid disorder.
Patients having any major illness like uncontrolled diabetes mellitus.
Known case of Asthma, neurological disorders, anemia (Hb <10mg/dl).
Known case of Renal insufficiency, nephrotic syndrome.
Known case of severe Liver diseases.
Known case of HIV positive and HbsAg positive patients.
Immune compromised patients.
Any serious medical and psychological condition subjects will not be
included.
Blood Lipid profile according to NCEP -According to Adult Treatment
Panel
SR. NO. LIPID PANEL DESIRABLE HIGH RISK
1 Total Cholesterol < 200 mg /dl >240 mg/dl
2 LDL-C > 130mg/dl 160-189 mg/dl
3 HDL-C - Male
- Female
< 40 mg/dl
< 50 mg/dl
4 Triglycerides >150 mg/dl 200-499 mg/dl
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method